Superscan in First Posttherapeutic 177Lu-PSMA Scan
This case highlights the effectiveness of 177 Lu-PSMA therapy in a 70-year-old man with castration-resistant prostate cancer who has extensive skeletal metastases in posttherapeutic whole-body imaging. A 70-year-old man with extensive skeletal metastases underwent 4 cycles of 177 Lu-PSMA-617 therapy. A whole-body 177 Lu-PSMA scan after the first cycle showed diffuse skeletal lesions, with minimal PSMA uptake in the kidneys and salivary glands. A whole-body scan after the fourth cycle of 177 Lu-PSMA showed a complete response of skeletal metastases with normal PSMA uptake in the kidneys and salivary glands. According to RECİP 1.0, the patient was considered a complete response.
Authors
- Fari̇se Yılmaz (ORCID: https://orcid.org/0000-0001-8136-513X)
- Merve Ni̇da Calderon Tobar (ORCID: https://orcid.org/0009-0007-6126-8384)
- Lütfü Perktaş (ORCID: https://orcid.org/0009-0008-0705-4665)
Institutions
- Selçuk University (TR)
- Corporation for Public Broadcasting (US)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1097/rlu.0000000000005624
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42